CF
CAH icon

C.T. Fitzpatrick’s Cardinal Health CAH Stock Holding History

C.T. Fitzpatrick’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-465
Closed -$22K – 54
2019
Q2 		$22K Hold
465
– – ﹤0.01% 53
2019
Q1 		$22K Sell
465
-7
-1% -$351 ﹤0.01% 49
2018
Q4 		$21K Sell
472
-615
-57% -$32.1K ﹤0.01% 49
2018
Q3 		$59K Hold
1,087
– – ﹤0.01% 52
2018
Q2 		$53K Sell
1,087
-4,952,317
-100% -$281M ﹤0.01% 55
2018
Q1 		$310M Buy
4,953,404
+167,134
+3% +$11.5M 2.5% 17
2017
Q4 		$293M Buy
4,786,270
+161,654
+3% +$9.99M 2.4% 16
2017
Q3 		$309M Buy
4,624,616
+267,169
+6% +$18.9M 2.65% 15
2017
Q2 		$340M Buy
4,357,447
+66,247
+2% +$5M 3.03% 12
2017
Q1 		$350M Sell
4,291,200
-41,518
-1% -$3.27M 3.02% 13
2016
Q4 		$312M Buy
+4,332,718
New +$313M 2.78% 14

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIG
American International Group New York $2.93M AUM 12.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

C.T. Fitzpatrick's CAH Position: Q3 2019 in Review

C.T. Fitzpatrick sold out of Cardinal Health (CAH) in Q3 2019, closing a stake of 465 shares — an estimated $22K sold.

C.T. Fitzpatrick first reported a position in CAH in Q4 2016 and held it in 11 quarters. The position peaked at $350M in Q1 2017. 664 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

  • C.T. Fitzpatrick reported no remaining Cardinal Health position as of Q3 2019 after selling out during the quarter.
  • C.T. Fitzpatrick sold 465 Cardinal Health shares in Q3 2019, an estimated $22K.
  • C.T. Fitzpatrick first reported a position in Cardinal Health in Q4 2016 and held it in 11 quarters.
  • C.T. Fitzpatrick's Cardinal Health position peaked at $350M in Q1 2017.
  • 664 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on Vulcan Value Partners's 13F filing for Q3 2019, filed 14 Nov 2019.